Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[carl_52fl]

To try to make a long story short:

The merger agreement of Oct. 1st gave the old GTEC 25% of the new company, and LJPC 75%. LJPC's shares after being converted to common shares were 299+M or for simplicity sake 300M. Old GTEC holders including management stock options were 100M.

Checking the Oct. 9th SEC filing, the LJPC's share distribution of individual owners totalled about 292M. There is no mention of the 8M in escrow for Greenview Capital after they complete their equity financing task, but I will assume they are there, since they are not accounted for anywhere else.

This is the 2% of the company's stock referred to in my last post.

We also know that fully diluted shares are now 430M since Pope financial bought an additional 30M for $8.2M.

It may be advantageous to inquire with Mr. Crocker to what are more details of the terms of GTEC's agreement with Greenview Capital, such as, after the stock price rises, must it be within a certain percent discount to current PPS, etc.

There is no stated deadline for Greenview, but you would think they would be highly motivated, seeing that, upon completion of the $30M in financing, they have 8M shares.